Zepbound (Tirzepatide) 4 doses - Médetone

Zepbound (Tirzepatid) 4 doz

€999,00

Weight management for high BMI

Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.

Fiyata neler dahildir?

Tedavinize uygun olması durumunda tıbbi danışmanlık ve reçete içerir, tedaviniz hazırlanarak evinize teslim edilir. Tedavinizi desteklemek ve ilerlemeyi izlemek için sürekli klinik takipler ve kontroller sağlanır.

Garantiler

Onaylanan siparişler için aynı gün gönderim
Gizli ve mahrem teslimat
Uzman klinik rehberlik
Hızlı müşteri desteği

Geçerli kimlik gereklidir

Reçete düzenlenmeden ve bu ilaç verilmeden önce kimlik doğrulaması gereklidir. Siparişinizi verdikten sonra geçerli bir kimlik belgesi sağlamanız istenecektir. Kabul edilen kimlik türleri arasında ulusal kimlik kartı, pasaport veya sürücü belgesi bulunmaktadır.

Güç: 2.5 mg

2.5 mg
5 mg
7.5 mg
10 mg
12.5 mg
15 mg

Ürün Çeşitleri

Our customers say Excellent Rated 4.7 Trustpilot Trustpilot

Zepbound Tirzepatide Weight Loss Injections

Hızlı özet

İlaç türü

Dual GIP and GLP-1 receptor agonist.

Çalışma prensibi

Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.

Etkin madde

Tirzepatide

İçinde etkili

Within a few weeks.

Jenerik mi?

No

Yan etkiler

Nausea, vomiting, diarrhea, decreased hunger, stomach pain, and constipation.

How it works

Clinician-led care, designed to be simple from start to finish.

1

Step 1

Check eligibility

Answer a short 2-minute questionnaire so we can understand your goals and medical history.

2

Step 2

Doctor approval

If eligible, one of our doctors issues your free prescription within 24 hours.

3

Step 3

Fast delivery, ongoing support

Next-day delivery across the EU, with support at every step of your treatment.

İlaç detayları

Açıklama

Zepbound (tirzepatid), obezite (BKİ ≥ 30 kg/m²) veya en az bir kilo ile ilişkili komorbiditeye sahip fazla kilolu (BKİ ≥ 27 kg/m²) yetişkinlerde kronik kilo yönetimi için haftada bir uygulanan subkutan GLP-1 reseptör agonisti ve GIP reseptör agonistidir. Klinik kanıtlar, vücut ağırlığını azaltmada ve kalori kısıtlaması ve artan fiziksel aktiviteyi içeren yaşam tarzı değişiklikleri ile birlikte kardiyometabolik parametreleri iyileştirmede etkinliğini göstermektedir. Zepbound, orta-şiddetli obstrüktif uyku apnesi ve eşlik eden obezitesi olan hastalarda apne-hipopne indeksi şiddetini azaltmada potansiyel fayda göstermiştir. Kontrendikasyonlar arasında diğer tirzepatid içeren formülasyonlar veya GLP-1 reseptör agonisti ilaçlarla eşzamanlı kullanım yer almaktadır. Pediatrik güvenlik ve etkinlik henüz belirlenmemiştir. Tedavi, nitelikli bir sağlık uzmanı tarafından başlatılmalı ve izlenmelidir. Bu ürün sadece reçeteyle kullanılmak içindir.

Kullanım talimatı

To use Zepbound effectively, start with the prescribed dose, injecting once a week on the same day. Administer injections in the abdomen, thigh, or upper arm, rotating sites to avoid irritation. Before injecting, clean your hands and the injection area. Let refrigerated medication warm slightly for comfort. Use clean techniques for needle attachment and injection, disposing of sharps properly. Store the medication in the fridge or briefly at room temperature as allowed. If a dose is missed, take it soon if within a few days; otherwise, skip it and never double dose. Regularly consult with your healthcare provider to adjust doses and discuss any side effects. Always follow your healthcare provider's detailed instructions.

Bileşenler

Tirzepatide, the active substance in Zepbound, works by mimicking the actions of natural hormones in the body that regulate blood sugar and appetite. As a dual GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-like Peptide-1) receptor agonist, it enhances insulin secretion in response to high blood sugar levels, slows down gastric emptying, and reduces appetite and food intake, leading to improved glycemic control and weight loss in adults with type 2 diabetes mellitus.

Yan etkiler

Gastrointestinal issues (nausea, vomiting, diarrhea, constipation), potential hypoglycemia (especially when used with other diabetes medications), injection site reactions, and possibly others depending on the individual's health condition and other medications being taken.

Uyarılar

When using Zepbound (tirzepatide), important precautions include being vigilant for severe abdominal pain indicative of pancreatitis, monitoring blood sugar levels due to the risk of hypoglycemia when combined with other diabetes medications, reporting any changes in urination that could signal kidney issues, and seeking immediate medical attention for persistent digestive problems like vomiting or diarrhea. It's also crucial to inform your doctor of any personal or family history of thyroid cancer, given studies in rodents linking Zepbound-like medications to thyroid issues. Be alert for signs of allergic reactions, and if you're pregnant or breastfeeding, consult with your healthcare provider about potential risks.

Hikayeleriniz, bizim gururumuz

Sıkça Sorulan Sorular

How quickly does Zepbound start to work?

The onset of Zepbound's effects can vary, but patients may begin to see improvements in their blood sugar levels and weight within a few weeks of starting treatment. Continuous use in conjunction with diet and exercise enhances its efficacy.

Do I need a prescription for Zepbound?

Yes, Zepbound is a prescription medication. You will need to consult a healthcare provider to determine if it's appropriate for your condition and to receive a prescription. Using our online consultation service will enable you to answer a short questionnaire that would be used by one of our clinical prescribers to determine your eligibility for the treatment and approve or decline and refund your order.

How is Zepbound administered?

Zepbound is administered as a subcutaneous injection once a week. It can be injected into the abdomen, thigh, or upper arm, with the site of injection rotated each week to minimise the risk of skin irritation.

How should Zepbound be stored?

Zepbound should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the pen in its original packaging to protect from light. Once in use, it may be kept at room temperature for 30 days.

What is the difference between Wegovy and Zepbound?

Wegovy and Zepbound are both injectable medications used primarily for weight management in adults, but they differ in their active ingredients and mechanisms of action.

Wegovy:

Active Ingredient: Semaglutide.
Mechanism of Action: Wegovy functions as a GLP-1 receptor agonist, mimicking the action of the glucagon-like peptide-1 hormone which regulates appetite and calorie intake. It enhances feelings of fullness and reduces hunger, leading to a reduction in food intake.
Usage: Approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.

Zepbound:

Active Ingredient: Tirzepatide.
Mechanism of Action: Zepbound is unique in that it acts as both a GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist. This dual action not only helps in reducing appetite and food intake like GLP-1 agonists but also enhances insulin secretion in a glucose-dependent manner and possibly affects fat metabolism.
Usage: Initially approved for the treatment of type 2 diabetes, with promising results in significant weight reduction, leading to its approval for use in obesity management as well.

While both medications are part of a broader category of drugs used for metabolic management, the dual mechanism of Zepbound may offer broader metabolic effects compared to Wegovy. Both have shown effectiveness in weight loss and improvements in various metabolic parameters in clinical trials, but the choice between them may depend on individual health profiles, specific medical conditions, and healthcare provider recommendations.

Uygunluğu kontrol et